Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (1): 8-12.DOI: 10.3969/j.issn.1673-8640.2021.01.002
Previous Articles Next Articles
AN Chongwen, LI Haixia(), JIAO Lili
Received:
2019-09-27
Online:
2021-01-30
Published:
2021-02-05
CLC Number:
AN Chongwen, LI Haixia, JIAO Lili. Establishment of reference interval for the detection of serum protein electrophoresis by V8 Nexus high speed automated capillary electrophoresis apparatus[J]. Laboratory Medicine, 2021, 36(1): 8-12.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.01.002
性别 | 例数 | 白蛋白 | α1球蛋白 | α2球蛋白 | β1球蛋白 | β2球蛋白 | γ球蛋白 | β球蛋白 |
---|---|---|---|---|---|---|---|---|
男性 | 318 | 64.11±2.84 | 3.72±0.51 | 5.94±1.30 | 6.43±0.86 | 4.29±0.73 | 15.51±2.39 | 10.71±1.32 |
女性 | 331 | 61.87±2.75* | 3.80±0.57 | 6.74±1.23* | 6.66±0.75* | 4.22±0.65 | 16.72±2.37* | 10.87±1.14 |
合计 | 649 | 62.96±3.01 | 3.76±0.54 | 6.35±1.32 | 6.54±0.81 | 4.25±0.69 | 16.13±2.46 | 10.80±1.23 |
性别 | 例数 | 白蛋白 | α1球蛋白 | α2球蛋白 | β1球蛋白 | β2球蛋白 | γ球蛋白 | β球蛋白 |
---|---|---|---|---|---|---|---|---|
男性 | 318 | 64.11±2.84 | 3.72±0.51 | 5.94±1.30 | 6.43±0.86 | 4.29±0.73 | 15.51±2.39 | 10.71±1.32 |
女性 | 331 | 61.87±2.75* | 3.80±0.57 | 6.74±1.23* | 6.66±0.75* | 4.22±0.65 | 16.72±2.37* | 10.87±1.14 |
合计 | 649 | 62.96±3.01 | 3.76±0.54 | 6.35±1.32 | 6.54±0.81 | 4.25±0.69 | 16.13±2.46 | 10.80±1.23 |
组别 | 例数 | 白蛋白 | α1球蛋白 | α2球蛋白 | β1球蛋白 | β2球蛋白 | γ球蛋白 | β球蛋白 |
---|---|---|---|---|---|---|---|---|
18~29岁组 | 63 | 64.54±2.94* | 3.75±0.53 | 6.27±1.57* | 6.15±0.93* | 4.25±0.75 | 15.05±2.35 | 10.41±1.42 |
30~39岁组 | 113 | 64.32±2.55* | 3.67±0.50 | 5.78±1.22* | 6.36±0.88* | 4.31±0.68 | 15.57±2.24 | 10.67±1.29 |
40~49岁组 | 74 | 64.06±3.04* | 3.66±0.47 | 5.74±1.15* | 6.61±0.81* | 4.20±0.79 | 15.73±2.44 | 10.80±1.31 |
50~59岁组 | 46 | 63.91±2.40* | 3.83±0.46 | 5.99±1.10* | 6.60±0.68* | 4.39±0.76 | 15.28±2.19 | 10.99±1.23 |
≥60岁 | 22 | 62.43±3.60 | 3.85±0.65 | 6.42±1.51 | 6.60±0.81 | 4.37±0.63 | 16.33±3.27 | 10.97±1.24 |
组别 | 例数 | 白蛋白 | α1球蛋白 | α2球蛋白 | β1球蛋白 | β2球蛋白 | γ球蛋白 | β球蛋白 |
---|---|---|---|---|---|---|---|---|
18~29岁组 | 63 | 64.54±2.94* | 3.75±0.53 | 6.27±1.57* | 6.15±0.93* | 4.25±0.75 | 15.05±2.35 | 10.41±1.42 |
30~39岁组 | 113 | 64.32±2.55* | 3.67±0.50 | 5.78±1.22* | 6.36±0.88* | 4.31±0.68 | 15.57±2.24 | 10.67±1.29 |
40~49岁组 | 74 | 64.06±3.04* | 3.66±0.47 | 5.74±1.15* | 6.61±0.81* | 4.20±0.79 | 15.73±2.44 | 10.80±1.31 |
50~59岁组 | 46 | 63.91±2.40* | 3.83±0.46 | 5.99±1.10* | 6.60±0.68* | 4.39±0.76 | 15.28±2.19 | 10.99±1.23 |
≥60岁 | 22 | 62.43±3.60 | 3.85±0.65 | 6.42±1.51 | 6.60±0.81 | 4.37±0.63 | 16.33±3.27 | 10.97±1.24 |
组别 | 例数 | 白蛋白 | α1球蛋白 | α2球蛋白 | β1球蛋白 | β2球蛋白 | γ球蛋白 | β球蛋白 |
---|---|---|---|---|---|---|---|---|
18~29岁组 | 86 | 62.35±2.25* | 3.79±0.54 | 6.83±1.18 | 6.49±0.78* | 4.15±0.65* | 16.39±2.01 | 10.65±1.21* |
30~39岁组 | 105 | 62.32±2.47* | 3.76±0.58 | 6.62±1.18 | 6.58±0.74* | 4.14±0.58* | 16.58±2.30 | 10.72±1.07* |
40~49岁组 | 86 | 61.23±3.02* | 3.85±0.59 | 6.63±1.21 | 6.85±0.78* | 4.24±0.64* | 17.20±2.34 | 11.09±1.10* |
50~59岁组 | 36 | 61.34±2.95* | 3.73±0.52 | 6.88±1.34 | 6.74±0.58* | 4.36±0.80* | 16.95±3.17 | 11.10±1.16* |
≥60岁 | 18 | 61.03±2.68 | 3.96±0.56 | 7.30±1.43 | 6.76±0.60 | 4.60±0.67 | 16.35±2.59 | 11.36±1.05 |
组别 | 例数 | 白蛋白 | α1球蛋白 | α2球蛋白 | β1球蛋白 | β2球蛋白 | γ球蛋白 | β球蛋白 |
---|---|---|---|---|---|---|---|---|
18~29岁组 | 86 | 62.35±2.25* | 3.79±0.54 | 6.83±1.18 | 6.49±0.78* | 4.15±0.65* | 16.39±2.01 | 10.65±1.21* |
30~39岁组 | 105 | 62.32±2.47* | 3.76±0.58 | 6.62±1.18 | 6.58±0.74* | 4.14±0.58* | 16.58±2.30 | 10.72±1.07* |
40~49岁组 | 86 | 61.23±3.02* | 3.85±0.59 | 6.63±1.21 | 6.85±0.78* | 4.24±0.64* | 17.20±2.34 | 11.09±1.10* |
50~59岁组 | 36 | 61.34±2.95* | 3.73±0.52 | 6.88±1.34 | 6.74±0.58* | 4.36±0.80* | 16.95±3.17 | 11.10±1.16* |
≥60岁 | 18 | 61.03±2.68 | 3.96±0.56 | 7.30±1.43 | 6.76±0.60 | 4.60±0.67 | 16.35±2.59 | 11.36±1.05 |
组别 | 例数 | 白蛋白 | α1球蛋白 | α2球蛋白 | β1球蛋白 | β2球蛋白 | γ球蛋白 | β球蛋白 |
---|---|---|---|---|---|---|---|---|
男性 | ||||||||
19~59岁组 | 296 | 64.23±2.74 | 3.71±0.49 | 5.91±1.28 | 6.41±0.86 | 4.28±0.74 | 15.45±2.31 | 10.70±1.32 |
≥60岁组 | 22 | 62.43±3.60* | 3.85±0.65 | 6.42±1.51 | 6.60±0.81 | 4.37±0.63 | 16.33±3.27 | 10.97±1.24 |
女性 | ||||||||
18~59岁组 | 313 | 61.91±2.75 | 3.79±0.57 | 6.71±1.21 | 6.65±0.76 | 4.20±0.65 | 16.74±2.36 | 10.85±1.14 |
≥60岁组 | 18 | 61.03±2.68 | 3.96±0.56 | 7.30±1.43 | 6.76±0.60 | 4.60±0.67* | 16.35±2.59 | 11.36±1.05* |
组别 | 例数 | 白蛋白 | α1球蛋白 | α2球蛋白 | β1球蛋白 | β2球蛋白 | γ球蛋白 | β球蛋白 |
---|---|---|---|---|---|---|---|---|
男性 | ||||||||
19~59岁组 | 296 | 64.23±2.74 | 3.71±0.49 | 5.91±1.28 | 6.41±0.86 | 4.28±0.74 | 15.45±2.31 | 10.70±1.32 |
≥60岁组 | 22 | 62.43±3.60* | 3.85±0.65 | 6.42±1.51 | 6.60±0.81 | 4.37±0.63 | 16.33±3.27 | 10.97±1.24 |
女性 | ||||||||
18~59岁组 | 313 | 61.91±2.75 | 3.79±0.57 | 6.71±1.21 | 6.65±0.76 | 4.20±0.65 | 16.74±2.36 | 10.85±1.14 |
≥60岁组 | 18 | 61.03±2.68 | 3.96±0.56 | 7.30±1.43 | 6.76±0.60 | 4.60±0.67* | 16.35±2.59 | 11.36±1.05* |
性别 | 年龄/岁 | 例数 | 白蛋白 | α1球蛋白 | α2球蛋白 | β1球蛋白 | β2球蛋白 | γ球蛋白 | β球蛋白 |
---|---|---|---|---|---|---|---|---|---|
95%可信区间 | |||||||||
男性 | 19~78 | 318 | 58.55~69.67 | 2.73~4.71 | 3.40~8.49 | 4.74~8.11 | 2.86~5.72 | 10.83~20.20 | 8.13~13.30 |
女性 | 18~85 | 331 | 56.48~67.26 | 2.69~4.91 | 4.34~9.14 | 5.19~8.12 | 2.94~5.50 | 12.07~21.37 | 8.63~13.11 |
合计 | 649 | 57.07~68.86 | 2.71~4.81 | 3.76~8.94 | 4.95~8.13 | 2.89~5.61 | 11.32~20.94 | 8.38~13.21 | |
99%可信区间 | |||||||||
男性 | 19~78 | 318 | 56.79~71.42 | 2.42~5.02 | 2.59~9.29 | 4.21~8.64 | 2.40~6.17 | 9.34~21.68 | 7.31~14.11 |
女性 | 18~85 | 331 | 54.77~68.96 | 2.34~5.26 | 3.58~9.90 | 4.72~8.59 | 2.53~5.91 | 10.60~22.84 | 7.93~13.82 |
合计 | 649 | 55.21~70.72 | 2.37~5.15 | 2.94~9.76 | 4.45~8.64 | 2.46~6.04 | 9.79~22.46 | 7.61~13.98 |
性别 | 年龄/岁 | 例数 | 白蛋白 | α1球蛋白 | α2球蛋白 | β1球蛋白 | β2球蛋白 | γ球蛋白 | β球蛋白 |
---|---|---|---|---|---|---|---|---|---|
95%可信区间 | |||||||||
男性 | 19~78 | 318 | 58.55~69.67 | 2.73~4.71 | 3.40~8.49 | 4.74~8.11 | 2.86~5.72 | 10.83~20.20 | 8.13~13.30 |
女性 | 18~85 | 331 | 56.48~67.26 | 2.69~4.91 | 4.34~9.14 | 5.19~8.12 | 2.94~5.50 | 12.07~21.37 | 8.63~13.11 |
合计 | 649 | 57.07~68.86 | 2.71~4.81 | 3.76~8.94 | 4.95~8.13 | 2.89~5.61 | 11.32~20.94 | 8.38~13.21 | |
99%可信区间 | |||||||||
男性 | 19~78 | 318 | 56.79~71.42 | 2.42~5.02 | 2.59~9.29 | 4.21~8.64 | 2.40~6.17 | 9.34~21.68 | 7.31~14.11 |
女性 | 18~85 | 331 | 54.77~68.96 | 2.34~5.26 | 3.58~9.90 | 4.72~8.59 | 2.53~5.91 | 10.60~22.84 | 7.93~13.82 |
合计 | 649 | 55.21~70.72 | 2.37~5.15 | 2.94~9.76 | 4.45~8.64 | 2.46~6.04 | 9.79~22.46 | 7.61~13.98 |
[1] | 苏学飞. 百色地区健康成人与病人血清蛋白成分含量分析[J]. 右江民族医学院学报,1993,15(1):17-19. |
[2] | 邵丽丽,潘瑾,李海峰. 266例健康人血清蛋白电泳参考值及两种电泳载体结果比较[J]. 第三军医大学学报,1999,21(11):799-804. |
[3] | 施志农,陈继梅,陈健康. 成人自动化血清蛋白电泳参考值的建立[J]. 蚌埠医学院报,2004,29(6):568-569. |
[4] | 竺澎波,关平,曾少芳. 应用凝胶电泳仪检测健康人血清蛋白组分参考值评析[J]. 现代医院,2004,4(1):28-29. |
[5] | 陈燕,黄泽玉,王雅杰,等. 全自动多通道毛细管区带电泳法在血清蛋白分析中的临床应用[J]. 中华检验医学杂志,2006,29(5):420-423. |
[6] | 中华人民共和国卫生部. 临床实验室检验项目参考区间的制定[S]. WS/T 402-2012,北京:中华人民共和国卫生部,2012. |
[7] | 张华欣,齐心亮,张峰,等. 兰州市健康人血清蛋白电泳参考值及2种电泳介质的结果评价[J]. 甘肃科学学报,2004,16(2):50-52. |
[8] | 周爱花,韩平治,常若云. 血清蛋白电泳分析系统方法学探讨[J]. 国际检验医学杂志,2008,29(7):661-662. |
[9] | 陈扬,张淑芳,冯女. 应用Helena Spife 3000全自动电泳仪建立血清蛋白的参考区间[J]. 山东医药,2009,49(36):94-95. |
[10] | 方宏罡,董秀鹏,车璐. 大庆地区自动化电泳仪血清蛋白电泳成人参考值的建立及与其它测定方法的比较[J]. 大家健康(学术版),2012,6(7):63-64. |
[11] | 张海晨,宋云霄,钟琦,等.电泳法与化学法检测健康人血清蛋白组分和白/球蛋白比值差异探讨[J]. 检验医学,2007,22(5):604-606. |
[12] | 商宝文,李建远. 血液病检验与临床[M]. 北京:专利文献出版社,1997. |
[1] | AN Yinghong, YAO Kechun, SU Chengming, TANG Jinhua, YANG Lixin, GAO Jie, XU Yanting, YAN Qiuhong, ZHAN Hongyan, MA Yueyun. Survey of serum homocysteine levels of apparently healthy subjects in Beijing [J]. Laboratory Medicine, 2023, 38(11): 1036-1040. |
[2] | ZHAO Yanhong, FU Lin, LIU Biao, XIAO Meifang. Reference interval of lactate dehydrogenase among 3-14-year-old population in Hainan [J]. Laboratory Medicine, 2023, 38(11): 1041-1043. |
[3] | XU Qianqian, JIANG Wangqing, SHEN Linjie, LU Yingjie, CHEN Jian, JIANG Haoqin. Establishment of the reference intervals for related parameters of adult reticulocytes in Shanghai [J]. Laboratory Medicine, 2022, 37(7): 641-645. |
[4] | MIAO Linzi, LU Yao, QU Chenxue, YOU Ran, GONG Yan. Establishment of the reference intervals of leukocyte surface CD64 and HLA-DR indexes for healthy adults and related factors [J]. Laboratory Medicine, 2022, 37(3): 240-245. |
[5] | LU Youli, YANG Shuangshuang, ZHANG Meiwei, OU Meixian, DONG Chunxia, SHEN Weiwei, JIANG Fengli, LI Shuijun. Simultaneous determination of 5 steroid hormones in human serum by ultra-performance liquid chromatography-tandem mass spectrometry and establishment of reference intervals in healthy adults [J]. Laboratory Medicine, 2022, 37(2): 165-173. |
[6] | YU Jianhong, PENG Qingyuan, YIN Minggang. Establishment of reference intervals of serum PGⅠ,PGⅡ and PGR for apparently healthy subjects in Zigong [J]. Laboratory Medicine, 2022, 37(1): 23-27. |
[7] | LI Jing, QUAN Hui, ZENG Zhirong, WEI Yi. Establishment of the reference interval of small and dense low-density lipoprotein cholesterol in apparently healthy adults in Chengdu [J]. Laboratory Medicine, 2021, 36(6): 609-614. |
[8] | WANG Zipeng, OUYANG Changli, GENG Deqin, WANG Dunjing. Establishment of cerebrospinal fluid IL-6 reference interval in non-inflammatory central nervous system diseases [J]. Laboratory Medicine, 2021, 36(6): 627-630. |
[9] | YUE Bo, LI Danjie, TANG Dahai, LIU Manjiao, HE Jialei, JIANG Mengjie, WEI Xiaoqiang. Establishment of a new algorithm for the reference interval of relative change values and application evaluation [J]. Laboratory Medicine, 2021, 36(6): 667-673. |
[10] | JI Zhi, DENG Lingyan, LI Jiaoyuan, WANG Xu, LI Huijun, CHENG Liming. Reference interval establishment of serum cytokeratin 19 fragment for healthy adults in Wuhan [J]. Laboratory Medicine, 2021, 36(5): 490-494. |
[11] | ZOU Ning, CHEN Guangxi, MA Hua, Qiurang, Zhaxinamo. Survey on the reference intervals of venous blood cells among native Tibetan adults in Aba county [J]. Laboratory Medicine, 2021, 36(2): 198-201. |
[12] | YUE Chaoyan, DUAN Chaohui, ZHANG Di, WEI Jie, LUO Xiaohong, ZHANG Qianlan, WU Yong, YING Chunmei. Performance evaluation of acridinium ester labeled direct chemiluminescence method for the detection of AMH and establishment of adult female AMH reference interval [J]. Laboratory Medicine, 2021, 36(1): 95-100. |
[13] | WU Qun, SHEN Junfei, WU Wenhao, WANG Beili, PAN Baishen, GUO Wei. Establishment of reference intervals of total bilirubin and direct bilirubin by indirect method [J]. Laboratory Medicine, 2020, 35(8): 749-752. |
[14] | XU Shuang, LU Jin, ZHAO Lei, PEI Lin, JIA Mei, RONG Rong. Rule making of M protein recognition by serum protein electrophoresis and its application in M protein screening among healthy subjects [J]. Laboratory Medicine, 2020, 35(7): 668-672. |
[15] | DU Yuxuan, WANG Wei, HE Falin, ZHONG Kun, YUAN Shuai, LIU Jiali, ZHANG Zhixin, WANG Zhiguo. Investigation and analysis on pediatric reference intervals of routine chemistry items in China [J]. Laboratory Medicine, 2020, 35(7): 676-681. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||